AIDS 2022

Aug. 2, 2022

As AIDS2022 closes, UNAIDS urges world leaders to act with courage to end AIDS

As AIDS2022 in Montreal comes to a close, UNAIDS Executive Director Winnie Byanyima said:

"Thanks to the dedication of thousands of scientists around the world, the determined organizing of civil society groups, and the support of key policy makers, the issues lifted up at AIDS2022 could enable a turning point in the global AIDS response. The new UNAIDS report released at the conference, In Danger, shows how the AIDS response has been blown off course, making action urgent.

The research presented at this conference provides new data, important scientific progress, and further evidence on the biomedical, social, and policy interventions needed to stop the AIDS pandemic. The insights and data shared by community organizations showed concretely how we can stop AIDS from snatching a life every minute and ways to tackle the inequalities driving the AIDS pandemic.

We are deeply saddened by how many researchers, officials, and people living with HIV from Africa, Asia, and Latin America were unable to come to the conference in Canada because they were unable to secure a visa. The host country of the next global AIDS conference, two years from now, must be one that guarantees that this will not be repeated and that those most affected by HIV can be fully at this important table.

Important steps forward were taken in Montreal.

This was a breakthrough conference for new long-acting ARVs to stop HIV. New research showed that injectable PrEP is among the most effective tools for preventing HIV available and that it works well in multiple populations. The World Health Organization released new guidelines and drugmaker ViiV has announced licenses for generic manufacturing of the drug in 90 countries. This could be a game changer if ViiV can provide an affordable price for low- and middle-income countries now, in the tens of dollars not hundreds of dollars, since it will be several years before generic production comes online and if generics are made available beyond these original 90 countries. 

The commitments made by African leaders and by international partners who have come together in the new global alliance to end AIDS in children could, if followed through, ensure that every child living with HIV is on antiretroviral medicine, and that no more children are infected with HIV. 

We thank the ministers and other political leaders who took part in the Conference, appreciate PEPFAR and Global Fund for the commitment demonstrated here, and call upon the many leaders who did not attend to take seriously the findings of this conference.

In particular, we call upon governments to urgently increase funding for the Global Fund and for the UN Joint Programme to enable the findings of this conference to turn into reality on the ground. As UNAIDS new report, In Danger, highlighted, courageous political leadership is essential to end AIDS and save millions of lives.”

 
New data from UNAIDS on the global HIV response reveals that during the last two years of COVID-19 and other global crises, progress against the HIV pandemic has faltered, resources have shrunk, and millions of lives are at risk as a result. Read UNAIDS Global AIDS Update 2022
 
UNAIDS
The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030. Learn more at unaids.org and connect with us on FacebookTwitterInstagram and YouTube.  
 
Aug. 2, 2022


IAS – the International AIDS Society – welcomed Sharon Lewin (Australia) as the next IAS President and Beatriz Grinsztejn (Brazil) as President-Elect today. IAS leadership also expressed deep gratitude to Adeeba Kamarulzaman (Malaysia) who steps down as IAS President and assumes her role as immediate-past President.



Lewin, a world-renowned infectious diseases physician and basic scientist, is also the inaugural Director of the Peter Doherty Institute for Infection and Immunity, a joint venture of the University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia. For more on Sharon’s extraordinary work and accomplishments, please click here.



Addressing delegates at the closing ceremony of AIDS 2022, the 24th International AIDS Conference, Lewin outlined her vision and explained why she remains an optimist about the strength of the global HIV response.


"AIDS 2022 has made it clear once again: progress happens when we come together and unleash the power of our movement. That is why the IAS exists. That is why we need to double down on our efforts to unite the voices of activists, policy makers and scientists," Lewin said.



"At AIDS 2022, we called on the world to re-engage and follow the science, and I can think of no better leader than Sharon to champion this cause and assume the leadership of the IAS," Kamarulzaman said of her successor. "These past two years, as another pandemic overtook the planet, Sharon’s pioneering HIV cure research and analysis have become even more important, providing a roadmap for the global response to COVID-19."



Similarly, Lewin expressed her admiration for Kamarulzaman and her leadership of the IAS over the past two years.



"Adeeba has spent decades challenging stigma, dismissing taboos and shattering glass ceilings," Lewin said. "She brought this tenacity to her two-year term, leading the IAS through the uncertainty of the COVID-19 pandemic and a historic era, including our first-ever hybrid conference. As a woman in science, I look forward to the day when two consecutive female presidents isn’t remarkable – but today it is and I’m proud to be a part of this new era."



As Lewin assumes her new role as IAS President, Beatriz Grinsztejn assumes her role of President-Elect. Grinsztejn, an infectious diseases physician, is the Director of the STD/AIDS Clinical Research Laboratory and principal investigator of the FIOCRUZ HIV Prevention and Therapeutic Clinical Trials Unit in Rio de Janeiro.



The IAS also announced newly elected members of its Governing Council, which determines strategy and policy direction for IAS to ensure that the organization fulfils its mission.

Jul. 29, 2022

29 July 2022 (Montreal, Canada)  The Journal of the International AIDS Society (JIAS) has launched a special issue, titled “Getting to the heart of stigma across the HIV continuum of care”, at AIDS 2022, the 24th International AIDS Conference.
 
The content of the special issue was guided by Guest Editors Lucy Stackpool-Moore (International AIDS Society, Switzerland, and Watipa, Australia), Carmen H Logie (University of Toronto, Canada) and Allanise Cloete (Human Sciences Research Council, South Africa). 
 
Despite decades of scientific advances in HIV prevention and treatment, the failure to progress in the global HIV response directly connects to intersecting individual and structural stigmas and discrimination from service provision to service uptake. Research shows that HIV-related stigma acts as a barrier to accessing prevention methods, HIV testing uptake, treatment initiation and adherence to antiretroviral therapy. Yet, the impacts of stigma and discrimination across the HIV care continuum are often overlooked.
 
This special issue draws attention to HIV-related and intersecting stigma and discrimination across the HIV prevention and care continuum, providing a state-of-the-field update about the latest concepts, innovative research methods and strategies to reduce stigma and its harmful effects.
 
Taken together, the collection of articles offers insights into a range of health conditions and social identities that shape lived experiences of stigma through a variety of methodologies, including qualitative, quantitative, systems mapping and systematic review. Examples of resilience, good practice and community leadership are presented.
 
Efforts to reduce new HIV acquisitions and improve HIV prevention and treatment programmes will remain suboptimal if HIV-related stigma is considered in isolation. If progress in reaching HIV epidemic control is to continue, increased emphasis and funding must be placed on addressing stigma and discrimination and ultimately improving quality of life and access to healthcare for people living with and most affected by HIV.
 
Access the special issue here: https://bit.ly/JIAS_Stigma

 ###

The Journal of the International AIDS Society (JIAS) is the official peer-reviewed journal of the IAS. Founded in 2004, it is an open-access, PubMed- and Medline-indexed journal. JIAS articles are published online on an article-by-article basis. The journal’s primary purpose is to provide an open-access platform for the generation and dissemination of evidence from a wide range of HIV-related disciplines, encouraging research from low- and middle-income countries. In addition, JIAS aims to strengthen capacity and empower less-experienced researchers from resource-limited countries.

For more information, visit www.jiasociety.org. 



IAC  the International AIDS Conference  is the premier global platform to advance the HIV response. As the world’s largest conference on HIV and AIDS, it sits uniquely at the intersection of science, advocacy and human rights, bringing together scientists, policy makers, healthcare professionals, people living with HIV, funders, media and community. Since its start in 1985, the conference continues to serve as an opportunity to strengthen policies and programmes that ensure an evidence-based response to HIV and related epidemics.

The 24th International AIDS Conference – known as AIDS 2022 – will be hosted in Montreal, Canada, and virtually from 29 July to 2 August 2022.

For more information, visit www.aids2022.org


 

IAS – the International AIDS Society – convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being. After the emergence of HIV and AIDS, concerned scientists created the IAS to bring together experts from across the world and disciplines to promote a concerted HIV response.  

Today, the IAS and its members unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all those living with and affected by HIV.  

The International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference. 

For more information, visit www.iasociety.org. 

 

Jul. 28, 2022

The opening session starts at 09:00 EDT tomorrow, 29 July

Kick off the conference by attending the opening session starting at 09:00 EDT (Eastern Daylight Time) tomorrow, 29 July, in Room 220 e/d or tuning in virtually on Channel 1.

Welcome to Canada by the Indigenous Knowledge Keepers
Sedalia Fazio, Canada
Michael Standup, IAS Group - CAAN, Canada


Introduction by the AIDS 2022 Master of Ceremonies
Omar Sharif Jr, actor, model, author and longtime LGBTQ+ advocate, Canada

Official opening of AIDS 2022 by the conference Co-Chairs
Jean-Pierre Routy, McGill University, Canada
Adeeba Kamarulzaman, IAS President and University of Malaya, Malaysia

Community welcome and address
Tim McCaskell, AIDS ACTION NOW!, Canada

Keynote remarks
Winnie Byanyima, UNAIDS, Switzerland

Welcome remarks by the Canadian government
Harjit S. Sajjan, Minister of International Development


A high-powered panel, including André Picard, Linda-Gail Bekker, Rachel Ong and John Nkengasong, discuss why and how the world must re-engage and follow the science to overcome the HIV epidemic as a threat to public health and individual well-being.

The session concludes with the unveiling of the AIDS Quilt, which celebrates the lives of thousands of people who have died due to AIDS, and a kaleidoscope of Canadian song by Barbara Lewis and Doug Balfour.

We are looking forward to seeing you there!